Microenvironment-sensing, nanocarrier-mediated delivery of combination chemotherapy for pancreatic cancer

Priyanka Ray1, Gauthami Nair2, Arnab Ghosh3,4

  • 1Department of Coatings and Polymeric Materials, North Dakota State University, Fargo, ND, 58108, USA.

Insights

This study developed a novel pH-sensing nanocarrier for co-delivering Gemcitabine (GEM) and an ERK inhibitor to treat pancreatic cancer, improving drug delivery and efficacy.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Oncology

Background:

  • Limited efficacy of current pancreatic cancer treatments necessitates novel therapeutic strategies.
  • Challenges in clinical translation of ERK inhibitors include off-target effects and toxicity.
  • Combination therapy with Gemcitabine (GEM) and ERK inhibitors shows promise but faces delivery hurdles.

Purpose of the Study:

  • To develop a pharmaceutical nanoformulation for co-delivery of GEM and an ERK inhibitor (SCH 772984).
  • To create a pH-sensing nanocarrier (NC) for controlled drug release and targeted delivery in pancreatic cancer.
  • To evaluate the feasibility of this combination therapy for improved pancreatic cancer treatment.

Main Methods:

  • Fabrication of a pH-sensing nanocarrier (NC) from a self-assembling triblock copolymer.
  • Co-stabilization of GEM (conjugated) and SCH 772984 (encapsulated) within the NC.
  • Characterization of NCs (hydrodynamic diameter: 161 nm) and assessment of drug loading content (GEM: 20.2%, SCH 772984: 18.3%).
  • Evaluation of pH-mediated drug release, cellular uptake, and anti-proliferative effects on pancreatic cancer cells.

Main Results:

  • Successfully developed a pH-sensing NC capable of co-delivering GEM and SCH 772984.
  • NCs demonstrated controlled drug release triggered by pH changes in the tumor microenvironment.
  • The nanoformulation effectively suppressed pancreatic cancer cell proliferation and showed accumulation at disease sites.
  • Demonstrated successful traffic through cellular membranes and engagement of target receptors.

Conclusions:

  • Co-delivery of GEM and an ERK inhibitor via a pH-sensing nanocarrier is feasible for pancreatic cancer treatment.
  • The developed NC platform offers a promising strategy for targeted drug delivery and overcoming challenges associated with combination chemotherapy.
  • This approach holds potential for enhanced therapeutic outcomes in pancreatic cancer by responding to the tumor microenvironment.

Related Concept Videos

The Sense of Self: Reflected Self-Appraisal and Social Comparison02:57

The Sense of Self: Reflected Self-Appraisal and Social Comparison

According to Charles Cooley, we base our image on what we think other people see (Cooley 1902). We imagine how we must appear to others, then react to this speculation. We don certain clothes, prepare our hair in a particular manner, wear makeup, use cologne, and the like—all with the notion that our presentation of ourselves is going to affect how others perceive us. We expect a certain reaction, and, if lucky, we get the one we desire and feel good about it. But more than that, Cooley...
55.6K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.7K
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
724
Introduction to Special Senses01:26

Introduction to Special Senses

Sensory receptors play an integral part in comprehending our external and internal environments. They receive diverse stimuli, converting them into the nervous system's electrochemical signals. This conversion occurs as the stimulus alters the sensory neuron's cell membrane potential, instigating the generation of an action potential. This action potential is subsequently transmitted to the central nervous system (CNS), which integrates with other sensory data or higher cognitive...
7.3K
Tactile and Chemical Senses01:27

Tactile and Chemical Senses

Tactile senses encompass touch, temperature, and pain, each mediated by specific receptors. Touch receptors detect mechanical energy or pressure against the skin. Sensory fibers from these receptors enter the spinal cord and relay information to the brain stem. Here, most fibers cross over to the opposite side of the brain. The touch information then moves to the thalamus, which projects a map of the body's surface onto the somatosensory areas of the parietal lobes in the cerebral cortex.
745
Receptor-mediated Endocytosis01:39

Receptor-mediated Endocytosis

Overview
110.8K